MedPath

FENOMAX

FENOMAX

Discontinued
DIN Number

02250004

Drug Class

Human

Market Date

Nov 14, 2006

Company
HC

Cipher Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02250004
AIG Number0118895004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AB05 FENOFIBRATE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification24:06.06
Health Canada Classification

ACTIVE INGREDIENTS (1)

FENOFIBRATEActive
Strength: 160 MG
Monograph: FENOFIBRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.